References
- Joshi K, Lin J, Lingohr-Smith M, Fu DJ, Muser E. Treatment patterns and antipsychotic medication adherence among commercially insured patients with schizoaffective disorder in the United States. Journal of clinical psychopharmacology. 2016 Oct;36(5):429.
- Jiang Y, McCombs JS, Park SH. A retrospective cohort study of acute kidney injury risk associated with antipsychotics. CNS drugs. 2017 Apr 1;31(4):319-26.
- Sood L, Owen A, Saini M. Olanzapine-induced rhabdomyolysis. Irish Journal of psychological medicine. 2006 Sep;23(3):114-5.
- Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009 Oct 1;67(9):272-83.
- Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis–an overview for clinicians. Critical care. 2004 Apr 1;9(2):158.
- Virupannavar S, Volkov S. An Unusual Presentation of Rhabdomyolysis in a Newly Diagnosed Sjögren’s Syndrome Associated Polymyositis. Archives of rheumatology. 2016 Sep;31(3):281.
- Savage DC, Forbes M, Pearce GW. Idiopathic rhabdomyolysis. Archives of disease in childhood. 1971 Oct 1;46(249):594-607.
- Rodríguez-Quintero JH, Ramos-Pineda A, Salas-Villela R, Gotés-Palazuelos J. Refractory hypercalcemia after idiopathic rhabdomyolysis. Clinical Cases in Mineral & Bone Metabolism. 2018 Sep 1;15(3):358-363.
- Watson JD, Gifford SM, Clouse WD. Biochemical markers of acute limb ischemia, rhabdomyolysis, and impact on limb salvage. In Seminars in vascular surgery. WB Saunders. 2014 Dec; 27(3-4):176-181)
- Jiang W, Wang X, Zhou S. Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis. Expert opinion on drug safety. 2016 Mar 3;15(3):357-65.
- Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. New England Journal of Medicine. 2009 Jul 2;361(1):6272.
- Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clinical chemistry and laboratory medicine. 2010 Jun 1;48(6):749-56.
- Onofrei SD, Radulescu D, Peride I, Niculae A, Checherita IA. Fibroblast Growth Factor 23 and Cardiovascular Outcome in Acute Kidney Injury. Revista de Chimie. 2019 Apr 1;70(4):126871.
- Zutt R, Van Der Kooi AJ, Linthorst GE, Wanders R.J., De Visser M. Rhabdomyolysis: review of the literature. Neuromuscular Disorders. 2014 Aug 1;24(8):651-9.
- Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Critical Care. 2014 Jun;18(3):224.
- Ronco C, Bellomo R, Kellum JA. Critical care nephrology. Philadelphia, USA: Saunders.
- Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrology Dialysis Transplantation. 1994 Jan 1;9(6):637-41.
- Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: complications and treatment. European journal of internal medicine. 2008 Dec 1;19(8):56874.
- Pinkston R, Walker LA. Multiorgan system failure caused by valproic acid toxicity. The American journal of emergency medicine. 1997 Sep 1;15(5):504-6.
- Altintepe L, Guney I, Tonbul Z, Türk S, Mazi M, Ağca E, Yeksan M. Early and intensive fluid replacement prevents acute renal failure in the crush cases associated with spontaneous collapse of an apartment in Konya. Renal failure. 2007 Jan 1;29(6):737-41.
- Checheriţă IA, David C, Ciocalteu A, Lascăr I, Budală LA. Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status. Rom J Morphol Embryol. 2013;54(3):539-43.
- Antoon JW, Chakraborti C. Corticosteroids in the treatment of alcohol-induced rhabdomyolysis. Elsevier. In Mayo Clinic Proceedings. 2011 Oct 1;86(10):1005-1007.
- Waring WS, Wrate J, Bateman DN. Olanzapine overdose is associated with acute muscle toxicity. Human & experimental toxicology. 2006 Dec;25(12):735-40.